ArticlePLOS global public health2024

Discontinuation of tenofovir disoproxil fumarate from initial ART regimens because of renal adverse events: An analysis of data from four multi-country clinical trials.

McNeil Ngongondo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.